Literature DB >> 9112411

Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex.

B Frenkel1, C Capparelli, M Van Auken, D Baran, J Bryan, J L Stein, G S Stein, J B Lian.   

Abstract

The bone-specific osteocalcin gene is a well established marker of osteoblast activity. We have studied osteocalcin transcription in transgenic mice carrying rat osteocalcin promoter-chloramphenicol acetyltransferase (CAT) reporter constructs. Transgenic lines carrying each of the 1.7-, 1.1-, 0.72-, or 0.35-kilobase promoter constructs expressed the reporter gene in a tissue-specific manner. However, each of these constructs was sensitive to site of integration effects, reflected by a high frequency of nonexpressing transgenic lines. High expression of the 1.7-kilobase promoter in osseous tissues was accompanied by low ectopic expression in the brain. Analysis of CAT expression in femurs, calvariae, and lumbar vertebrae of this line indicated considerable variability in promoter activity among individual transgenic animals. Analysis of the variance in CAT activity demonstrated a linkage between promoter activities in these distant skeletal sites. Promoter activity was inversely correlated with age, and females exhibited severalfold higher activity than age-matched males. Bone marrow stromal cells from these animals, cultured under conditions that support osteoblast differentiation, exhibited the expected postproliferative onset of osteocalcin promoter activity, as assessed by CAT assay. The ex vivo CAT activity was not dependent on the sex or the age of the donor transgenic mouse. Taken together, our results are consistent with the hypothesis that a common, probably humoral, factor(s) regulates osteocalcin transcription in distant skeletal sites. We suggest that the abundance of this factor(s) is different between males and females and among individual mice at a given time point, and that ex vivo culturing of osteoblasts reduces the variation in osteocalcin promoter activity by eliminating the physiological contribution of this factor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112411     DOI: 10.1210/endo.138.5.5105

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy.

Authors:  Z Hou; Q Nguyen; B Frenkel; S K Nilsson; M Milne; A J van Wijnen; J L Stein; P Quesenberry; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Peripheral cannabinoid receptor, CB2, regulates bone mass.

Authors:  Orr Ofek; Meliha Karsak; Nathalie Leclerc; Meirav Fogel; Baruch Frenkel; Karen Wright; Joseph Tam; Malka Attar-Namdar; Vardit Kram; Esther Shohami; Raphael Mechoulam; Andreas Zimmer; Itai Bab
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

3.  Misexpression of CCAAT/enhancer binding protein beta causes osteopenia.

Authors:  Stefano Zanotti; Lisa Stadmeyer; Anna Smerdel-Ramoya; Deena Durant; Ernesto Canalis
Journal:  J Endocrinol       Date:  2009-02-13       Impact factor: 4.286

4.  Connective tissue growth factor is a target of notch signaling in cells of the osteoblastic lineage.

Authors:  Ernesto Canalis; Stefano Zanotti; Anna Smerdel-Ramoya
Journal:  Bone       Date:  2014-05-02       Impact factor: 4.398

5.  Rutin promotes osteogenic differentiation of periodontal ligament stem cells through the GPR30-mediated PI3K/AKT/mTOR signaling pathway.

Authors:  Bin Zhao; Yixuan Xiong; Yunpeng Zhang; Linglu Jia; Wenjing Zhang; Xin Xu
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-09

6.  Osteoblast lineage-specific effects of notch activation in the skeleton.

Authors:  Ernesto Canalis; Kristen Parker; Jian Q Feng; Stefano Zanotti
Journal:  Endocrinology       Date:  2012-12-28       Impact factor: 4.736

7.  Progressive recruitment of Runx2 to genomic targets despite decreasing expression during osteoblast differentiation.

Authors:  Steven Pregizer; Sanjeev K Baniwal; Xiting Yan; Zea Borok; Baruch Frenkel
Journal:  J Cell Biochem       Date:  2008-11-01       Impact factor: 4.429

8.  Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene.

Authors:  Mohammad Q Hassan; Amjad Javed; Maria I Morasso; Jeremy Karlin; Martin Montecino; Andre J van Wijnen; Gary S Stein; Janet L Stein; Jane B Lian
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.

Authors:  Anna Smerdel-Ramoya; Stefano Zanotti; Lisa Stadmeyer; Deena Durant; Ernesto Canalis
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

10.  Notch inhibits osteoblast differentiation and causes osteopenia.

Authors:  Stefano Zanotti; Anna Smerdel-Ramoya; Lisa Stadmeyer; Deena Durant; Freddy Radtke; Ernesto Canalis
Journal:  Endocrinology       Date:  2008-04-17       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.